
About Muzi
Muzi is a Healthcare company based in San Francisco (United States) founded in 2016. RDTs are interpreted using smartphones and AI on Muzis platform. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its competitors include Genalyte, Enumera Molecular and Radiolife; 2 of its 3 listed competitors have raised funding.
Company details
Founded in 2016 at Singularity University and based in San Francisco, United States, Muzi functions in the health technology sector. Smartphones are integrated with diagnostic tests and AI to interpret rapid diagnostic tests accurately. Electronic health records are generated, and epidemiology data is collected. Operations involve two-factor biometric authentication, QR code validation, and image recognition for test processing. Scanned results are provided to facilitate diagnostics in various settings.
- Headquarters San Francisco, United States
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website muzitech.com
- Social LinkedIn
Competitors of Muzi
Muzi has 3 listed competitors in our database, 2 of them funded. They include Genalyte, Enumera Molecular and Radiolife.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genalyte.com | 2007 | San Diego, United States | $141.8M | 113 | Silicon photonics-based multiplexing tools for biomolecular detection are developed. | |
| enumeramolecular.com | 2022 | Ann Arbor, United States | $18.72M | Liquid biopsy tools are developed for biomolecule assessment. | ||
| radiolifelabs.com | 2021 | Wilmington, United States | AI and radio-frequency signatures are used for diagnostics and therapeutics. |
Detailed competitors of Muzi
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Muzi (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Muzi
Muzi was founded in 2016.
Muzi is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Founded in 2016 at Singularity University and based in San Francisco, United States, Muzi functions in the health technology sector. Smartphones are integrated with diagnostic tests and AI to interpret rapid diagnostic tests accurately. Electronic health records are generated, and epidemiology data is collected. Operations involve two-factor biometric authentication, QR code validation, and image recognition for test processing. Scanned results are provided to facilitate diagnostics in various settings.
Muzi's top competitors include Genalyte, Enumera Molecular and Radiolife.